Bio Products Laboratory
The Bio Products Laboratory (BPL) is a company involved in the manufacture of human blood plasma products, located in Elstree in the United Kingdom. BPL was a state owned organization and it was part of the U.K. National health Service for most of its existence. Today BPL is owned by the Creat Group, a Chinese investment firm. Before August 2016, it had been owned by Bain Capital (80%) and the UK Government (20%) via holding company Plasma Resources UK Ltd. BPL is run as a commercial business and supplies plasma derived products to the National Health Service in the UK as well as to markets in over 45 countries.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Albuminex | Albumin (human) | 2018-06-19 | — | |
| Coagadex | Coagulation factor x (human) | 2015-10-20 | — | |
| Gammaplex | Immune globulin intravenous (human) | 2009-09-17 | — |
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use